BFS
KRYS icon

Bare Financial Services’s Krystal Biotech KRYS Stock Holding History

Bare Financial Services’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.8K Buy
72
+25
+53% +$7.47K 0.01% 175
2026
Q1 		$12.1K Buy
47
+4
+9% +$1.06K ﹤0.01% 265
2025
Q4 		$10.6K Hold
43
– – ﹤0.01% 226
2025
Q3 		$7.59K Hold
43
– – ﹤0.01% 341
2025
Q2 		$5.91K Buy
43
+32
+291% +$4.7K ﹤0.01% 387
2025
Q1 		$1.98K Buy
+11
New +$1.85K ﹤0.01% 271

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bare Financial Services's KRYS Position: Q2 2026 in Review

Bare Financial Services increased its Krystal Biotech (KRYS) stake by 53% in Q2 2026, buying an estimated $7.47K and bringing the position to 72 shares worth $26.8K. The position accounts for 0.01% of the portfolio, ranked #175.

Bare Financial Services first reported a position in KRYS in Q1 2025 and has held it in 6 quarters since. 424 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Bare Financial Services held 72 shares of Krystal Biotech worth $26.8K as of Q2 2026.
  • Bare Financial Services bought 25 Krystal Biotech shares in Q2 2026, an estimated $7.47K.
  • Krystal Biotech made up 0.01% of Bare Financial Services's portfolio in Q2 2026, its #175 holding.
  • Bare Financial Services first reported a position in Krystal Biotech in Q1 2025 and has held it in 6 quarters since.
  • 424 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Bare Financial Services's 13F filing for Q2 2026, filed 27 Jul 2026.